QUOTE AND NEWS
SeekingAlpha  Apr 4  Comment 
By Jason Napodano: On March 31, 2014, Cytomedix, Inc. (OTCQX:CMXI) reported financial results for the fourth quarter and full year ended December 31, 2013. Total revenues in the quarter were $3.5 million, an increase of 65% over the fourth...
SeekingAlpha  Apr 1  Comment 
Cytomedix, Inc. (OTCQX:CMXI) Q4 2013 Results Earnings Conference Call April 01, 2014, 08:00 AM ET Executives Michael Wood - MD, LifeSci Advisors, Investor Relations. Martin Rosendale - CEO Steven A. Shallcross - EVP, CFO, Secretary...
DailyFinance  Dec 2  Comment 
2014 Payment Level Will Support Broad AutoloGel Expansion in the Outpatient MarketGAITHERSBURG, MD -- (Marketwired) -- 12/02/13 -- Cytomedix, Inc. (OTCQX: CMXI), a leading developer of biologically active regenerative therapies, announced today...
OilVoice  Oct 26  Comment 
Zhaikmunai L.P. LSE ZKM the oil and gas exploration and production enterprise with assets in northwestern Kazakhstan announces that its Gas Treatment Facility GTF is fully operational following
Reuters  Aug 10  Comment 
The outlook revision follows Zhaikmunai's strong operating performance in the first quarter of 2012, with production more than doubling following the successful ramp up of the company's newly completed gas treatment facility (GTF). We anticipate...
Flightglobal  Jul 9  Comment 
SS White Technologies (H4/A4) is providing key components for Pratt & Whitney's variable area fan nozzle technology on the Bombardier CSeries programme,...
FierceBiotech  Feb 9  Comment 
Just 10 months after abandoning its second effort to go public, Aldagen is selling out to a small regenerative medicine company for just $16 million in shares and the chance to earn another chunk of stock based on the clinical success of its stem...
Globe Newswire  Nov 14  Comment 
GAITHERSBURG, Md., Nov. 14, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced financial results for
Globe Newswire  Nov 11  Comment 
GAITHERSBURG, Md., Nov. 11, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI) (the "Company"), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, announced today that the Centers for
Globe Newswire  Nov 8  Comment 
GAITHERSBURG, Md., Nov. 8, 2011 (GLOBE NEWSWIRE) -- Cytomedix, Inc. (OTCBB:CMXI), a leading developer of biologically active regenerative therapies for wound care, inflammation and angiogenesis, today announced that the Company will release financial





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki